2007 GASTROINTESTINAL CANCERS SYMPOSIUM
Multidisciplinary Approches to the Prevention, Diagnosis, and Therapy of GI Cancers
Cancers of the Esophagus and Stomach—Friday, January 19
Exhibit Hall Open
7:00 AM — 6:30 PM
Breakfast Available
7:00 AM — 8:00 AM
Welcome
7:45 AM — 8:00 AM
- General Session I: Prevention, Screening, and Diagnosis
8:00 AM — 9:30 AM
Chair: Antoni Castells, MD, MPH — University of Barcelona
- Primary Prevention of Gastric Cancer: Is It Time for Massive Helicobacter pylori Eradication?
Francis Mégraud, PhD – Hospital Pellegrin, Bordeaux, France
Chemoprevention of Esophageal Cancer in the Background of Barrett’s Esophagus
Prateek Sharma, MD – Kansas University Medical Center
Nutritional Support in Patients with Esophageal and Gastric Cancers: Defining Appropriate Management and Intervention
Janet Lee Abrahm, MD – Dana-Farber Cancer Institute
Abstract Discussion
Question-and-Answer Session
Break
9:30 AM – 9:45 AM
- General Session II: Multidisciplinary Treatment
9:45 AM – 11:30 AM
Chair: Christopher Crane, MD — M. D. Anderson Cancer Center
- Extent of Lymphadenectomy in Gastric Resection: Have We Finally Come to a Consensus?
Mitsuro Sasako, MD, PhD – National Cancer Center Hospital, Japan
Integration of Targeted Agents into Chemotherapy and Chemoradiation Regimens for Esophageal and Gastric Cancers
Katja Ott, MD – Technische Universitat Munich
Post-operative Chemoradiation Therapy for Gastric Cancer: Indications and Challenges
Joel Tepper, MD – University of North Carolina, Chapel Hill
Expert Perspective: Review of Neoadjuvant Therapy for Esophagogastric Cancers: Chemotherapy, Radiotherapy, or Both
David Ilson, MD – Memorial Sloan-Kettering Cancer Center
Abstract Discussion
Question-and-Answer Session
General Poster Session A (Box Lunches Available)
11:30 AM – 1:00 PM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Fellows, Residents, and Junior Faculty Luncheon
Additional Registration Required
11:30 AM – 1:00 PM
Oral Abstract Presentation Session A
1:00 PM – 2:15 PM
Chairs: Nicholas Petrelli, MD – Helen F. Graham Cancer Center
Leonard Gunderson, MD – Mayo Clinic, Scottsdale
Break
2:15 PM – 2:30 PM
- General Session III: Translational Research
2:30 PM – 4:00 PM
Chair: Martin S. Karpeh, Jr., MD — State University of New York at Stony Brook
- Genetic Predisposition to Gastric Cancer
Carlos Caldas, PhD – University of Cambridge, UK
Integration of Targeted Agents into Cheomotherapy and Chemoradiation Regimens Esophageal and Gastric Cancers
Howard Safran, MD – Brown University
Have Biological Markers of Targeted Therapy Helped?
S. Gail Eckhardt, MD – University of Colorado Cancer Center
Abstract Discussion
Question-and-Answer Session
Break
4:00 PM – 4:15 PM
- General Session IV: Controversies
4:15 PM – 5:30 PM
Chair: Mitchell C. Posner, MD – University of Chicago Hospital
- Management of Barretts’ Esophagus and Dysplasia: Surgery is Mandatory
James Luketich, MD – University of Pittsburgh Medical Center
Management of Barretts’ Esophagus and Dysplasia: Who Needs Surgery?
Kenneth Wang, MD – Mayo Clinic, Rochester
Rebuttal
Question-and-Answer Session
General Poster Session B (Wine and Cheese Available)
5:30 PM – 6:30 PM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract—Saturday, January 20
Meet the Professor Sessions (Breakfast Available)
Additional Registration Required
6:45 AM — 7:45 AM
Exhibit Hall Open
7:00 AM — 6:30 PM
Breakfast Available
7:00 AM — 8:00 AM
Welcome
7:45 AM — 8:00 AM
- General Session I: Prevention, Screening, and Diagnosis
8:00 AM — 9:30 AM
Chair: David Linehan, MD — Washington University School of Medicine
- Screening for Familial Pancreatic Cancer: Clinical and Genetic Insights
Gloria Petersen, PhD – Mayo Clinic College of Medicine
Evaluation of Bile Duct Strictures: How Do We Know if it is Cancer?
Oleh Haluszka, MD – Fox Chase Cancer Center
Advances in the Imaging of Hepatobiliary Cancers
Larry Schwartz, MD – Memorial Sloan-Kettering Cancer Center
Abstract Discussion
Question-and-Answer Session
Break
9:30 AM – 9:45 AM
- General Session II: Multidisciplinary Treatment
9:45 AM – 11:30 AM
Chair: Vincent Yang, MD, PhD – Emory University School of Medicine
- Locally Advanced vs. Metastatic Pancreatic Cancer: Do We Need to Treat These Groups of Patients Differently?
James Abbruzzese, MD – MD Anderson Cancer Center
Chemoembolisation and Ablation for HCC Techniques
Jordi Bruix, MD – Hospital Clinic, Barcelona
Conformal Radiation Therapy for Primary Hepatobiliary Cancers
Laura Dawson, MD – Princess Margaret Hospital
Bile Duct Cancer: How Aggressive Should We Be?
Michael Haddock, MD – Mayo Clinic Rochester
Abstract Discussion
Question-and-Answer Session
General Poster Session C (Box Lunches Available)
11:30 AM – 1:00 PM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Oral Abstract Presentation Session B
1:00 PM – 2:15 PM
Chairs: Bruce Minsky, MD – University of Chicago Medical Center
Richard Schilsky, MD – University of Chicago
Break
2:15 PM – 2:30 PM
- General Session III: Translational Research
2:30 PM – 4:00 PM
Chair: Françoise Mornex, MD – Centre Hospitalier Lyon Sud, Lyon, France
- Epigenetic Inactivation of Tumor Suppressor Genes in HCC
Winnie Yeo, MD – Chinese University of Hong Kong
GIST: The Use of Detailed Mutational Analysis to Guide Therapy
Charles Blanke, MD – Oregon Health Sciences University
Why is Pancreatic Cancer So Difficult to Treat? Stem Cell Resistance in Pancreas Cancer
Diane Simeone, MD – University of Michigan
Abstract Discussion
Question-and-Answer Session
Break
4:00 PM – 4:15 PM
- General Session IV: Controversies
4:15 PM – 5:30 PM
Chair: Eric Van Cutsem, MD – University Hospital Gasthuisberg, Leuven
- Now or Later: The Best Timing for Adjuvant Therapy in Pancreatic Cancer Management
Postoperative Treatment: Margaret Tempero, MD – University of California San Francisco
Preoperative Treatment: Doug Evans, MD – MD Anderson Cancer Center
Rebuttal
Question-and-Answer Session for Panel
General Poster Session D (Wine and Cheese Available)
5:30 PM – 6:30 PM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Cancers of the Colon and Rectum—Sunday, January 21
No Exhibits General Poster Session E (Breakfast Available)
7:00 AM — 8:00 AM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Welcome
7:45 AM — 8:00 AM
- General Session I: Prevention, Screening, and Diagnosis
8:00 AM – 9:30 AM
Chair: Scott Kuwada, MD – University of Utah Huntsman Cancer Institute
- Novel Endoscopic Modalities for CRC Screening
Nadir Arber, MD, MSc – Tel Aviv Sourasky Medical Center
Management of the Patient with Multiple Polyps: How to Differentiate MAP, FAP, and Other Polyposis Syndromes
Steve Gallinger, MD – Mount Sinai Hospital
Optimal Use of PET/CT Scans in the Diagnosis and Management of CRC
Bonnie N. Joe, MD, PhD – University of California San Francisco
Abstract Discussion
Question-and-Answer Session
Break
9:30 AM – 9:45 AM
- General Session II: Multidisciplinary Treatment
9:45 AM – 11:30 AM
Chair: Bernard Nordlinger, MD – Hospital Ambroise Pare in France
- Innovations in Radiation Therapy of Rectal Carcinoma: The Role of Intensity Modulated Radiation Therapy and Other Novel Agents
William Blackstock, MD – Wake Forest University
Downstaging of Liver Disease for “Cure”: Is This the End of Palliative Chemotherapy?
René Adam, MD – Hopital Paul Brousse, Villejuif, France
Chemotherapy Free Intervals: Heresy or Here to Stay?
Aimery de Gramont, MD – Hopital Saint-Antoine, Paris
Expert Opinion and Perspective
Daniel Haller, MD – University of Pennsylvania
Abstract Discussion
Question-and-Answer Session
General Poster Session F (Box Lunches Available)
11:30 AM – 12:30 PM
Selected topic-related abstracts will be on display, with the authors available for informal discussion.
Oral Abstract Presentation Session
12:30 PM – 1:45 PM
Chairs: Daniel Chung, MD – Massachusetts General Hospital
Richard Goldberg, MD – University of North Carolina, Chapel Hill School of Medicine
Break
1:45 PM – 2:00 PM
Keynote Lecture: Prevention of Colorectal Neoplasia: Defining Interventions and Targets
2:00 PM – 2:30 PM
Bernard Levin, MD – MD Anderson Cancer Center
- General Session III: Translational Research
2:30 PM – 3:30 PM
Chair: Emily K. Bergsland, MD – University of California San Francisco Cancer Center
- Overview of Ongoing Phase II Trials with Novel Targeted Therapies in CRC
Mace Rothenberg, MD – Vanderbilt Ingram Cancer Center
Molecular Imaging of Colonic Polyps and Cancer
Umar Mahmood, MD, PhD – Harvard Medical School
Abstract Discussion
Question-and-Answer Session
Break
3:30 PM – 3:45 PM
- General Session IV: Controversies
3:45 PM – 5:00 PM
Chairs: Christopher Willett, MD – Duke University Medical Center
Richard Goldberg, MD – University of North Carolina, Chapel Hill School of Medicine
- Can Local Excision Replace Radical Resection in the Management of Rectal Cancer?
Local Resection, Sphincter Preservation, and XRT
Heidi Nelson, MD – Mayo Clinic
Radical Resection, Rectectomy
José G. Guillem, MD – Memorial Sloan-Kettering Cancer Center
Rebuttal
Expert Opinion
Christopher Willett, MD – Duke University
Discussion/Question-and-Answer Session
Symposium Concludes
5:00 PM
|
